title: [Kaletra (lopinavir/ritonavir--a new HIV protease inhibitor].
authors.affiliation: N. F. Gamaleya Research Institute of Epidemiology and Microbiology, Research Centre of Drug Evaluation, Moscow.
authors.forename: F I
authors.initials: FI
authors.lastname: Ershov
authors.forename: N V
authors.initials: NV
authors.lastname: Kas'ianova
authors.forename: A N
authors.initials: AN
authors.lastname: Vasil'ev
mesh_terms: D015658:HIV Infections / Q000188:drug therapy*; D017320:HIV Protease Inhibitors / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D061466:Lopinavir; D011744:Pyrimidinones / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D019438:Ritonavir / Q000009:adverse effects / Q000627:therapeutic use*
chemical_list: D017320:HIV Protease Inhibitors; D011744:Pyrimidinones; D061466:Lopinavir; D019438:Ritonavir
vernacular_title: Kaletra (lopinavir/ritonavir)--novyĭ ingibitor VICh-proteaz]